XREF LIMITED — Interim / Quarterly Report 2018

Jan 29, 2018

Appendix 4C

==> picture [147 x 34] intentionally omitted <==

Quarterly report for entities subject to Listing Rule 4.7B

Name of entity Xref Limited

Xref Limited
ACN 122 404 666 Consolidated statement of cash flows	Quarterended ("current quarter")
	31 December 17
1 Cash flows from operating activities 1.1 Receipts from customers 1.2 Payments for (a) research and development (b) product manufacturing and operating costs (c) advertising and marketing (d) leased assets (e) staff costs (f) administration and corporate costs 1.3 Dividends received 1.4 Interest received 1.5 Interest and other costs of finance paid 1.6 Income taxes paid 1.7 Government grants and tax incentives 1.8 Other (provide details if material) - GST on sales for the period - Net foreign exchange gain 1.9 Net cash from / (used in) operating activities	Current quarter $A'000 1,472 (214) (28) (285) (91) (2,016) (422) 33 1,385 150 (79)	Year to date (6 months) $A'000 2,806 (300) (255) (894) (404) (4,723) (1,185) 66 1,385 292 (48)
	(95)	(3,260)
2 Cash flows from investing activities 2.1 Payments to acquire (a) property, plant and equipment (b) businesses (item 10) (c) investments (d) intellectual property (e) other non-current assets 2.2 Proceeds from disposal of: (a) property, plant and equipment (b) businesses (item 10) (c) investments (d) intellectual property (e) other non-current assets 2.3 Cash flows from loans to other entities 2.4 Dividends received (see note 3) 2.5 Other (provide details if material) - 2.6 Net cash from / (used in) investing activities	(56) - - - - - - - - - - - -	(98) - - - - - - - - - - - -
	(56)	(98)

Xref Limited

Page 1 of 3

Appendix 4C - 31 December 2017

3 3.1 3.2 3.3 Proceeds from exercise of share options 3.4 3.5 Proceeds from borrowings 3.6 Repayment of borrowings 3.7 3.8 Dividends paid 3.9 Other (provide details if material) 3.10 Net cash from / (used in) financing activities Cash flows from financing activities Proceeds from issues of shares Proceeds from issue of convertible notes Transaction costs related to issues of shares, convertible notes or options Transaction costs related to loans and borrowings	Current quarter $A'000 - - - - - -	Year to date (6 months) $A'000 7,500 (484) - - - -
	-	7,016
4 4.1 4.2 4.3 4.4 4.5 Effect of movement in exchange rates on cash held 4.6 Cash and cash equivalents at end of quarter Net increase (decrease) in cash and cash equivalents for the period held Cash and cash equivalents at beginning of quarter /year to date Net cash from / (used in) operating activities (item 1.9 above) Net cash from / (used in) investing activities (item 2.6 above) Net cash from / (used in) financing activities (item 3.10 above)	Current quarter $A'000 7,930 (95) (56) - (53)	Year to date (6 months) $A'000 4,111 (3,260) (98) 7,016 (43)
	7,726	7,726
5 Reconciliation of cash and cash equivalents 5.1 Bank balances 5.2 Call deposits 5.3 Bank overdrafts 5.4 Other (provide details) 5.5 Cash and cash equivalents at end of quarter at the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts	Current quarter $A'000 7,655 71 - -	Previous quarter $A'000 7,859 71 - -
	7,726	7,930
6 6.1 6.2 Payments to directors of the entity and associates of the directors Aggregate amount of payments to these parties included in item 1.2 Aggregate amount of cash flow from loans to these parties included in item 2.3	Current quarter $A'000 193
	Current quarter $A'000 193
6.3 Include below any explanation necessary to understand the transactions included in items 6.1 and 6.2

Xref Limited

Page 2 of 3

Appendix 4C - 31 December 2017

• 7 Payments to related entities of the entity and Current associates of the related entities quarter $A'000

• 7.1 Aggregate amount of payments to these parties included 79

• in item 1.2

• 7.2 Aggregate amount of cash flow from loans to these parties included in item 2.3 - 7.3 Include below any explanation necessary to understand the transactions included in 7.1 and 7.2

• 8 Financing facilities available

8.1 Loan facilities 8.2 Credit standby arrangements 8.3 Other (please specify) Add notes as necessary for an understanding of the position.	Total facility amount at quarter end $A'000 - - -	Amount drawn at quarter end $A'000 - - -
8.4 Include below a description of each facility above, including the lender, interest rate and whether it is secured or unsecured. If any additional facilities have been entered into or are proposed to be entered into after quarter end, include details of those facilities as well.

• 8.4 Include below a description of each facility above, including the lender, interest rate and whether it is secured or unsecured. If any additional facilities have been entered into or are proposed to be entered into after quarter end, include details of those facilities as well.

• 9 Estimated cash outflows for next quarter

• 9.1 Research and Development

• 9.2 Product manufacturing and operating costs

• 9.3 Advertising and marketing

• 9.4 Leased assets

• 9.5 Staff costs

• 9.6 Administration and corporate costs

• 9.7 Other (provide details if material)

• 9.8 Total estimated cash outflows

10 Acquisitions and disposals of business

• 10.1 Name of entity

• 10.2 Place of incorporation or registration

• 10.3 Consideration for acquisition or disposal

• 10.4 Total net assets 10.5 Nature of business

$A'000
50
45
350
240
2450
275
3,410
Acquisitions	Disposals
n/a	n/a

Compliance statement

1 This statement has been prepared in accordance with accounting standards and policies which comply with Listing Rule 19.11A.

• 2 This statement does give a true and fair view of the matters disclosed.

Sign here:

Print name: James Solomons, CFO

Date: 30 January 2018

Xref Limited

Page 3 of 3

Appendix 4C - 31 December 2017